Morningstar

Countable Labs Announces Additional Modules for Countable PCR Expanding its Utility for Translational Research, Cell and Gene Therapy Manufacturing, and Diagnostic Development

Countable Labs, the developer of Countable PCR, the leading PCR innovation transforming how science measures biology, announced the launch of the RNA Module for Countable PCR. This new solution brings ...

Detecting and Characterizing RNA Drug Candidates to Accelerate Therapeutic Development, Upcoming Webinar Hosted by Xtalks

Advancing RNA therapeutics depends on understanding two critical questions: Where do drug candidates go, and what do they do ...

STORM Therapeutics and AlidaBio Announce Strategic Collaboration to Accelerate Development of Cancer Therapies Targeting RNA Modifications

STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration with Alida ...